COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 931: Articles 9301-9310  | Next

Evaluation of test-to-return after COVID-19 diagnosis in a Massachusetts public school district
Nelson, S. B., Brenner, I. R., Homan, E., Lee, S. B., Bongiorno, C., Pollock, N., Ciaranello, A. L.
10.1101/2022.02.11.22270843 — Posted: 2022-02-15
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
Lamacchia, G., Mazzoni, A., Spinicci, M., Vanni, A., Salvati, L., Peruzzi, B., Bencini, S., Capone, M., Carnasciali, A., Farahvachi, P., Rocca, A., Kiros, S. T., Graziani, L., Zammarchi, L., Mencarini, J., Colao, M. G., Caporale, R., Liotta, F., Cosmi, L., Rossolini, G. M., Bartoloni, A., Maggi, L., Annunziato, F.
10.1101/2022.02.14.22270857 — Posted: 2022-02-15
Combined oropharyngeal/nares and nasopharyngeal swab sampling remain effective for molecular detection of SARS-CoV-2 Omicron variant
Patriquin, G., LeBlanc, J. J., Gillis, H. A., McCracken, G. R., Pettipas, J. J., Hatchette, T. F.
10.1101/2022.02.13.22270891 — Posted: 2022-02-15
Predicting COVID-19 outbreak using open mobility data for minimal disruption on the country's economy
MORALES-FAJARDO, H. M., RODRIGUEZ-ARCE, J.
10.1101/2022.02.12.22270892 — Posted: 2022-02-15
SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, after the third wave, April-November 2021
Kleynhans, J., Tempia, S., Wolter, N., von Gottberg, A., Bhiman, J. N., Buys, A., Moyes, J., McMorrow, M. L., Kahn, K., Gomez-Olive, F. X., Tollman, S., Martinson, N. A., Wafawanaka, F., Lebina, L., du Toit, J., Jassat, W., Neti, M., Brauer, M., Cohen, C., the PHIRST-C Group
10.1101/2022.02.10.22270772 — Posted: 2022-02-15
Role of COVID-19 vaccinal status in admitted children during OMICRON variant circulation in Rio de Janeiro, city- Preliminary report
Araujo da Silva, A. R., de Carvalho, B. R. R., Esteves, M. d. M., Teixeira, C. H., Souza, C. V.
10.1101/2022.02.10.22270817 — Posted: 2022-02-15
Workplace infection control measures and romantic activities of workers during COVID-19 pandemic: a prospective cohort study in Japan
Fujino, Y., Okawara, M., Hino, A., Muramatsu, K., Nagata, T., Ikegami, K., Tateishi, S., Tsuji, M., Ishimaru, T.
10.1101/2022.02.13.22270825 — Posted: 2022-02-15
Strength and durability of antibody responses to BNT162b2 and CoronaVac
Cowling, B. J., Wong, I. O. L., Shiu, E. Y. C., Lai, A. Y. T., Cheng, S. M. S., Chaothai, S., Kwan, K. K. H., Martin-Sanchez, M., Poon, L. L. M., Ip, D. K. M., Leung, G. M., Leung, N. H. L., Peiris, M.
10.1101/2022.02.11.22270848 — Posted: 2022-02-15
Omicron Spike protein has a positive electrostatic surface that promotes ACE2 recognition and antibody escape
Gan, H. H., Zinno, J., Piano, F., Gunsalus, K.
10.1101/2022.02.13.480261 — Posted: 2022-02-14
SARS-CoV-2 Permissive Glioblastoma Cell Line for High Throughput Antiviral Screening
Vanhulle, E., Stroobants, J., Provinciael, B., Camps, A., Noppen, S., Maes, P., Vermeire, K.
10.1101/2022.02.13.480238 — Posted: 2022-02-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).